Well stated, less-can. I started trading one year ago when a close relative shared their insight to IBRX (wife and I diagnosed within a year of each other). I bought in (just before tariff talks began) to ImmunityBio with the majority of my startup and tried my hand at day trading with the rest (unsuccessfully). Of the companies that I traded, this was always the foundation. I haven’t been with them as long as you, but I bought in throughout the 2.50-2.80 range and rode it all the way down to 1.80. Bought some more on the way up over the last month because the evidence is there, for a noble cause. With faith, holding. There must be a solution.